© 2000 American Heart Association, Inc.
Editorial |
Electrical Heterogeneity, Cardiac Arrhythmias, and the Sodium Channel
From the Masonic Medical Research Laboratory, Utica, NY.
Correspondence to Dr Charles Antzelevitch, Masonic Medical Research Laboratory, 2150 Bleecker St, Utica, NY 13501.
Key Words: heterogeneity • sodium channels • cardiac arrhythmias
 |
Introduction |
|---|
 Top Introduction References |
|---|
It was not long ago that we thought of the ventricles of the heart as being composed of 2 basic cell types: specialized conducting cells that make up the His-Purkinje system and ventricular myocytes. Studies conducted over the last decade have highlighted the diversity among the cells that comprise the ventricular myocardium, pointing to regional differences in the electrical properties of cells as well as major distinctions in the response to pharmacological agents and pathophysiological states.1 2 Several interesting differences have been described between endocardium and epicardium, and a unique population of cells located in the midmyocardial layers has been identified and shown to display electrophysiological and pharmacological profiles different from those of epicardium and endocardium. These cells, known as M cells, have been observed in canine, guinea pig, rabbit, pig, and human ventricles.3 4 5 6 7 8
Epicardial, endocardial, and M cells differ in several ways, but principally with respect to repolarization characteristics. Ventricular epicardial and M cells display action potentials with a prominent transient outward current (Ito)-mediated phase 1, giving rise to a notched appearance of the action potential. The absence of a prominent notch in endocardium is a consequence of a much smaller Ito. Similar regional differences in Ito are found in canine, feline, rabbit, rat, and human ventricular myocytes.1 Recent studies also indicate that Ito and the action potential notch are much larger in right versus left ventricular epicardial9 and M10 cells. The transmural gradient in the amplitude of the Ito-mediated action potential notch underlies the normal J wave or J point elevation in the ECG,11 and its accentuation, particularly in the right ventricle, contributes to the development of life-threatening arrhythmias in patients with the Brugada syndrome and various forms of idiopathic ventricular fibrillation.12 13
M cells are distinguished by the ability of their action potential to prolong more than that of epicardium or endocardium in response to a slowing of rate or in response to agents with antiarrhythmic class III actions.3 These features of the M cell are attributable, at least in part, to the presence of a smaller slowly activating delayed rectifier current (IKs),14 a larger late sodium current (late INa),1 15 and a larger sodium-calcium exchange current.16 No transmural differences are apparent with respect to the rapidly activating delayed rectifier (IKr) and inward rectifier currents in the canine heart. However, transmural and apico-basal differences in the density of IKr channels have been described in the ferret heart.17
Electrophysiologically and pharmacologically, M cells display characteristics intermediate between those of Purkinje and ventricular cells. Studies involving canine arterially perfused wedge preparations have shown that transmural voltage gradients generated by differences in the time courses of repolarization of the 3 ventricular myocardial cell types are in large part responsible for the inscription of the electrocardiographic T wave and that amplification of these transmural heterogeneities of final repolarization can lead to the development of the long-QT syndrome.18 19 20
Perfused wedge and in vivo studies have shown that IKr blockers (eg, D-sotalol), calcium channel agonists (eg, BayK 8644), and agents that augment late INa (eg, ATX-II or anthopleurin-A) prolong the QT interval, increase transmural and interventricular dispersion of repolarization, and induce extrasystoles capable of precipitating torsade de pointes.18 19 20 21 22 23 24 25 Agents capable of prolonging action potential duration (APD), with the exception of the IKs blockers, amplify transmural dispersion by prolonging APD of the M cell more than that of epicardial or endocardial cells and by inducing early afterdepolarizations preferentially in M cells. Similar phenomena are observed in response to IKs blockers, but only in the presence of a ß-adrenergic agonist; otherwise, these agents produce a homogeneous prolongation of APD and no early afterdepolarizations.21 26
In a recent issue of Circulation Research, Sakmann et al27 made another important contribution to the heterogeneity literature demonstrating differences in late INa among cells spanning the ventricular wall of the guinea pig heart. Midmyocardial cells are shown to display a smaller late INa than epicardial or endocardial cells. This finding is opposite to that reported for the canine heart, where late INa density is considerably larger in M cells than in epicardial or endocardial cells and contributes importantly to the longer APD of the M cell. The disparity may be attributable to methodological considerations. Experiments involving isolated tissues indicate that the guinea pig heart is similar to that of the dog, containing M and transitional cells in the midmyocardium (deep subepicardium to deep subendocardium) and cells with much briefer APD, showing little response to IKr in the endocardial and epicardial layers.5 However, unlike the dog, dissociation of myocytes from smaller hearts is fraught with problems, because epicardial and endocardial cells are underrepresented.1 2 Indeed, studies involving dissociation of myocytes from guinea pig hearts have reported cells with electrophysiological and pharmacological profiles of M and transitional cells but not of endocardial or epicardial cells.28 Rather than lacking M cells, as suggested, these studies seem to be lacking in epicardial and endocardial cells.1 2 In most regions of the canine heart, M cells displaying the longest APD are localized in the deep subendocardial layers. If the same is true in the guinea pig heart, M cells with the longest APD would be expected to be found in the endocardial fraction. Indeed, previous studies by Bryant et al28 report that guinea pig cells with the longest APD are found in the endocardial fraction. Moreover, a subsequent report by the same groups indicates that these same cells abbreviate most in response to 100 nmol/L tetrodotoxin.29 Both observations are consistent with the finding by Sakmann et al27 of a large late INa in cells isolated from guinea pig endocardium.
Late INa in ventricular cells has received relatively little attention. Recent studies suggest that it plays a prominent role in maintaining the plateau of the action potential, determining APD and transmural dispersion of repolarization, and development of cardiac arrhythmias, particularly under conditions in which IKr and IKs are reduced (eg, long-QT syndrome, hypertrophic cardiomyopathy, chronic infarction, and heart failure).30 31 Although block of fast INa has fallen into disrepute as a target for the treatment of ventricular arrhythmias, late INa should not be dismissed categorically and seems deserving of some attention.
|
Acknowledgments |
|---|
This work was supported by grants from the National Institutes of Health (HL 47678), American Heart Association, New York State Affiliate, and Masons of New York State and Florida.
|
Footnotes |
|---|
The opinions expressed in this editorial are not necessarily those of the editors or of the American Heart Association.
|
References |
|---|
|
TopIntroductionReferences |
|---|
1. Antzelevitch C, Shimizu W, Yan GX, Sicouri S, Weissenburger J, Nesterenko VV, Burashnikov A, Di Diego JM, Saffitz JE, Thomas GP. The M cell: its contribution to the ECG and to normal and abnormal electrical function of the heart. J Cardiovasc Electrophysiol. 1999;10:1124–1152.[Medline] [Order article via Infotrieve]
2. Antzelevitch C, Dumaine R. Electrical heterogeneity in the heart: physiological, pharmacological and clinical implications. In: Page E, Fozzard HA, Solaro RJ, eds. Handbook of Physiology: The Heart. New York, NY: Oxford University Press. In press.
3.
Sicouri S,
Antzelevitch C. A subpopulation of cells with unique
electrophysiological properties in the deep subepicardium of the canine
ventricle: the M cell. Circ
Res. 1991;68:1729–1741.
4. Drouin E, Charpentier F, Gauthier C, Laurent K, Le Marec H. Electrophysiological characteristics of cells spanning the left ventricular wall of human heart: evidence for the presence of M cells. J Am Coll Cardiol. 1995;26:185–192.[Abstract]
5. Sicouri S, Quist M, Antzelevitch C. Evidence for the presence of M cells in the guinea pig ventricle. J Cardiovasc Electrophysiol. 1996;7:503–511.[Medline] [Order article via Infotrieve]
6.
Li GR, Feng J, Yue
L, Carrier M. Transmural heterogeneity of action potentials and Ito1 in
myocytes isolated from the human right ventricle.
Am J Physiol. 1998;275:H369–H377.
7. Rodriguez-Sinovas A, Cinca J, Tapias A, Armadans L, Tresanchez M, Soler-Soler J. Lack of evidence of M-cells in porcine left ventricular myocardium. Cardiovasc Res. 1997;33:307–313.[Medline] [Order article via Infotrieve]
8.
Stankovicova T,
Szilard M, De Scheerder I, Sipido KR. M cells and transmural
heterogeneity of action potential configuration in myocytes from the
left ventricular wall of the pig heart.
Cardiovasc Res. 2000;45:952–960.
9.
Di Diego JM, Sun
ZQ, Antzelevitch C.
Ito and
action potential notch are smaller in left vs. right canine ventricular
epicardium. Am J Physiol. 1996;271:H548–H561.
10.
Volders PG,
Sipido KR, Carmeliet E, Spatjens RL, Wellens HJ, Vos MA. Repolarizing
K+ currents ITO1, and IKs are larger in
right than left canine ventricular midmyocardium.
Circulation. 1999;99:206–210.
11.
Yan GX,
Antzelevitch C. Cellular basis for the electrocardiographic J wave.
Circulation. 1996;93:372–379.
12.
Yan GX,
Antzelevitch C. Cellular basis for the Brugada syndrome and other
mechanisms of arrhythmogenesis associated with ST segment elevation.
Circulation. 1999;100:1660–1666.
13. Antzelevitch C, P Brugada, J Brugada, R Brugada, K Nademanee, JA Towbin. The Brugada Syndrome. Armonk, NY: Futura; 1999:1–99.
14.
Liu DW,
Antzelevitch C. Characteristics of the delayed rectifier current
(IKr and
IKs) in
canine ventricular epicardial, midmyocardial and endocardial myocytes:
a weaker
IKs
contributes to the longer action potential of the M cell.
Circ Res. 1995;76:351–365.
15. Antzelevitch C, Yan GX, Shimizu W, Burashnikov A. Electrical heterogeneity, the ECG, and cardiac arrhythmias. In: Zipes DP, Jalife J, eds. Cardiac Electrophysiology: From Cell to Bedside. Philadelphia, Pa: WB Saunders; 1999:222–238.
16.
Zygmunt AC,
Goodrow RJ, Antzelevitch C.
INa-Ca
contributes to electrical heterogeneity within the canine ventricle.
Am J Physiol. 2000;278:H1671–H1678.
17.
Brahmajothi
MV, Morales MJ, Reimer KA, Strauss HC. Regional localization of ERG,
the channel protein responsible for the rapid component of the delayed
rectifier, K+ current in the ferret heart.
Circ Res. 1997;81:128–135.
18.
Yan GX,
Antzelevitch C. Cellular basis for the normal T wave and the
electrocardiographic manifestations of the long QT syndrome.
Circulation. 1998;98:1928–1936.
19.
Yan GX, Shimizu
W, Antzelevitch C. Characteristics and distribution of M cells in
arterially-perfused canine left ventricular wedge preparations.
Circulation. 1998;98:1921–1927.
20.
Shimizu W,
Antzelevitch C. Sodium channel block with mexiletine is effective in
reducing dispersion of repolarization and preventing torsade de pointes
in LQT2 and LQT3 models of the long-QT syndrome.
Circulation. 1997;96:2038–2047.
21.
Shimizu W,
Antzelevitch C. Cellular basis for the electrocardiographic features of
the LQT1 form of the long QT syndrome: effects of ß-adrenergic
agonists, antagonists and sodium channel blockers on transmural
dispersion of repolarization and torsade de pointes.
Circulation. 1998;98:2314–2322.
22. Weissenburger J, Nesterenko VV, Antzelevitch C. Transmural heterogeneity of ventricular repolarization under baseline and long QT conditions in the canine heart in vivo: torsades de pointes develops with halothane but not pentobarbital anesthesia. J Cardiovasc Electrophysiol. 2000;11:290–304.[Medline] [Order article via Infotrieve]
23.
El-Sherif N,
Chinushi M, Caref EB, Restivo M. Electrophysiological mechanism of the
characteristic electrocardiographic morphology of torsade de pointes
tachyarrhythmias in the long-QT syndrome: detailed analysis of
ventricular tridimensional activation patterns.
Circulation. 1997;96:4392–4399.
24. Verduyn SC, Vos MA, Van der Zande J, Kulcsar A, Wellens HJ. Further observations to elucidate the role of interventricular dispersion of repolarization and early afterdepolarizations in the genesis of acquired torsade de pointes arrhythmias: a comparison between almokalant and d-sotalol using the dog as its own control. J Am Coll Cardiol. 1997;30:1575–1584.[Abstract]
25.
Carlsson L,
Abrahamsson C, Andersson B, Duker GD, Schiller-Linhardt G.
Proarrhythmic effects of the class III agent almokalant: importance of
infusion rate, QT dispersion, and early afterdepolarisations.
Cardiovasc Res. 1993;27:2186–2193.
26. Burashnikov A, Antzelevitch C. Block of IKs does not induce early afterdepolarization activity but promotes ß-adrenergic agonist-induced delayed afterdepolarization activity in canine ventricular myocardium. J Cardiovasc Electrophysiol. 2000;11:458–465.[Medline] [Order article via Infotrieve]
27.
Sakmann BFAS,
Spindler AJ, Bryant SM, Linz KW, Noble D. Distribution of a persistent
sodium current across the ventricular wall in guinea pigs.
Circ Res. 2000;87:910–914.
28.
Bryant SM, Wan X,
Shipsey SJ, Hart G. Regional differences in the delayed rectifier
current
(IKr and
IKs)
contribute to the differences in action potential duration in basal
left ventricular myocytes in guinea-pig.
Cardiovasc Res. 1998;40:322–331.
29. Main MC, Bryant SM, Hart G. Regional differences in action potential characteristics and membrane currents of guinea-pig left ventricular myocytes. Exp Physiol. 1998;83:747–761.[Abstract]
30. Marbán E. Heart failure: the electrophysiologic connection. J Cardiovasc Electrophysiol. 1999;10:1425–1428.[Medline] [Order article via Infotrieve]
31.
Tomaselli GF,
Marbán E. Electrophysiological remodeling in hypertrophy and heart
failure. Cardiovasc Res. 1999;42:270–283.
This article has been cited by other articles:
 |
|
 |
|
  W.-Q. Wang, C. Robertson, A. K. Dhalla, and L. Belardinelli Antitorsadogenic Effects of ({+/-})-N-(2,6-Dimethyl-phenyl)-(4[2-hydroxy-3-(2-methoxyphenoxy)propyl]-1-piperazine (Ranolazine) in Anesthetized Rabbits J. Pharmacol. Exp. Ther., June 1, 2008; 325(3): 875 - 881. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Babai Bigi, A. Aslani, and S. Shahrzad Clinical predictors of atrial fibrillation in Brugada syndrome Europace, October 1, 2007; 9(10): 947 - 950. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. M.R. Orth, J. C. Hesketh, C. K.H. Mak, Y. Yang, S. Lin, G. N. Beatch, A. M. Ezrin, and D. Fedida RSD1235 blocks late INa and suppresses early afterdepolarizations and torsades de pointes induced by class III agents Cardiovasc Res, June 1, 2006; 70(3): 486 - 496. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Morita, K. Kusano-Fukushima, S. Nagase, Y. Fujimoto, K. Hisamatsu, H. Fujio, K. Haraoka, M. Kobayashi, S. T. Morita, K. Nakamura, et al. Atrial fibrillation and atrial vulnerability in patients with Brugada syndrome J. Am. Coll. Cardiol., October 16, 2002; 40(8): 1437 - 1444. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Members of the Sicilian Gambit New Approaches to Antiarrhythmic Therapy, Part II: Emerging Therapeutic Applications of the Cell Biology of Cardiac Arrhythmias Circulation, December 11, 2001; 104(24): 2990 - 2994. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Members of the Sicilian Gambit New approaches to antiarrhythmic therapy; emerging therapeutic applications of the cell biology of cardiac arrhythmias Eur. Heart J., December 1, 2001; 22(23): 2148 - 2163. [Abstract] [PDF]
|
|
|
|
|
|
Members of the Sicilian Gambit New approaches to antiarrhythmic therapy: emerging therapeutic applications of the cell biology of cardiac arrhythmias Cardiovasc Res, December 1, 2001; 52(3): 345 - 360. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Abriel, C. Cabo, X. H. T. Wehrens, I. Rivolta, H. K. Motoike, M. Memmi, C. Napolitano, S. G. Priori, and R. S. Kass Novel Arrhythmogenic Mechanism Revealed by a Long-QT Syndrome Mutation in the Cardiac Na+ Channel Circ. Res., April 13, 2001; 88(7): 740 - 745. [Abstract] [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||